$99 Osimertinib 80mg NSCLC EGFR T790M Inhibitor Tablet

Osimertinib is designed to target NSCLC, specifically the EGFR mutations like T790M. It’s available in 40 mg or 80 mg tablets with a film coating. The usual dosage is 80 mg a day, and you can take it with or without meals.

Each bottle comes with 30 tablets. It’s made to treat NSCLC with EGFR mutations, like those with the T790M kind. The dose is tailored to each person based on their cancer’s severity and how they respond.

We might change how often or how much you take.